PFENEX INC. AND AGILA BIOTECH PRIVATE LIMITED JOINT VENTURE AGREEMENTJoint Venture Agreement • June 25th, 2014 • Pfenex Inc. • Pharmaceutical preparations • England and Wales
This Joint Venture Agreement (this “Agreement”) is made as of the 7th day of March 2013 (the “Effective Date”), by and between Pfenex Inc., a Delaware corporation with a principal place of business located at 10790 Roselle Street, San Diego, CA 92121 (“Pfenex”), and Agila Biotech Private Limited, an India corporation with a principal place of business located at Strides House, Bilekahalli, Bannerghatta Road, Bangalore 560 076, India (“Agila”). Pfenex and Agila may be referred to individually as a “Party” or together as the “Parties.”
TECHNOLOGY LICENSING AGREEMENTTechnology Licensing Agreement • June 25th, 2014 • Pfenex Inc. • Pharmaceutical preparations • New York
This Technology Licensing Agreement (“Agreement”) is effective as of the Effective Date and is by and between Dow Global Technologies Inc. and/or The Dow Chemical Company (hereinafter both are referred to as “Dow”), both Delaware corporations having their principal offices at either 2040 Dow Center, Midland, MI, 48674 USA or 2030 Dow Center, Midland, MI, 48674 USA and Pfenex Inc., a Delaware corporation (hereinafter “Pfenex”) having a principal place of business at 5501 Oberlin Drive, San Diego, CA.
JOINT DEVELOPMENT & LICENSE AGREEMENTJoint Development and License Agreement • June 25th, 2014 • Pfenex Inc. • Pharmaceutical preparations • England and Wales
This Joint Development and License Agreement (this “Agreement”) is made as of the 31st day of December 2012 (the “Effective Date”), by and between Pfenex, Inc., a Delaware corporation with a principal place of business located at 10790 Roselle Street, San Diego, CA 92121 (“Pfenex”), and Agila Biotech Private Limited, company incorporated under the Companies Act, 1956 and having its registered office at Strides House, Bilekahalli, Bannerghatta Road, Bangalore 560 076, India (“Agila”). Pfenex and Agila may be referred to individually as a “Party” or together as the “Parties.”
SUBCONTRACT AGREEMENT FIRM FIXED PRICE COMMERCIAL ITEMS (GOVERNMENTSubcontract Agreement • June 25th, 2014 • Pfenex Inc. • Pharmaceutical preparations • Delaware
[*] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
